10.2.1 Drugs that enhance neuromuscular transmission

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

12 library items in 10.2.1 Drugs that enhance neuromuscular transmission

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

10: Musculoskeletal and joint diseases (remove) , 10.2 Drugs used in neuromuscular disorders (remove) , 10.2.1 Drugs that enhance neuromuscular transmissi (remove)

Sort by: Display summary:

Results 1 - 10 of 12

Result page:
Previous
|
1
2
|
Next

1.

SMC unable to recommend fampridine (Fampyra®) for improvement of walking in adult patients with multiple sclerosis with walking disability due to non-submission

Source: Scottish Medicines Consortium (SMC),
Date published: 10/04/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Multiple sclerosis

NeLM Area:

Evidence > Drug Specific Reviews

Link
2.

NETAG issues recommendation on fampridine (Fampyra®) in multiple sclerosis

Source: NETAG ,
Date published: 26/03/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Multiple sclerosis

NeLM Area:

Evidence > Drug Specific Reviews

Link to recommendation

Link to appraisal report
3.

Content variability of active drug substance in compounded oral 3,4-diaminopyridine products

Source: Journal of Clinical Pharmacy and Therapeutics,
Date published: 06/02/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Pharmaceutics

NeLM Area:

Evidence > Medicines Management > References

Abstract link
4.

How do you convert an oral pyridostigmine dose to a parenteral neostigmine dose?

Source: London Medicines Information Service,
Date published: 27/01/2012
Review date: 31/01/2014

Category:

10.2.1 Drugs that enhance neuromuscular transmission | FAQs | Neuromuscular disease

NeLM Area:

Evidence > Medicines Q & A

248.2final.doc
5.

NETAG issues recommendation on amifampridine phosphate (Firdapse®) for the symptomatic treatment of Lambert-Eaton Myasthenic Syndrome

Source: North East Treatment Advisory Group,
Date published: 05/12/2011

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Neuromuscular disease

NeLM Area:

Evidence > Drug Specific Reviews

Appraisal report

Recommendation
6.

What is the difference between amifampridine and 3,4-diaminopyridine base for Lambert-Eaton myasthenic syndrome in adults?

Source: Wessex Drug and Medicines Information Centre,
Date published: 12/09/2011
Review date: 31/05/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | FAQs | Neuromuscular disease

NeLM Area:

Evidence > Medicines Q & A

QA333_3amifampridine.doc
7.

Use of pyridostigmine in pregnancy

Source: UK Teratology Information Service,
Date published: 01/09/2011

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drugs in pregnancy

NeLM Area:

Evidence > Drugs in Pregnancy
8.

Updated IV Monograph on Neostigmine metilsulfate

Source: No information given,
Date published: 10/08/2011

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug Administration

NeLM Area:

News

Link- registration required

Link to FAQ on MEDUSA
9.

Neostigmine Methylsulphate Injection BP 2.5mg in 1ml - Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 15/04/2011

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes
10.

SMC does not recommend amifampridine (Firdapse®) for Lambert-Eaton Myasthenic Syndrome due to non-submission

Source: Scottish Medicines Consortium (SMC),
Date published: 09/11/2010

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Neuromuscular disease | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link

Results 1 - 10 of 12

Result page:
Previous
|
1
2
|
Next